The DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.
An Integrated Overview of HIV-1 Latency
Open accessAbstract
Despite significant advances in our understanding of HIV, a cure has not been realized for the more than 34 million infected with this virus. HIV is incurable because infected individuals harbor cells where the HIV provirus is integrated into the host’s DNA but is not actively replicating and thus is not inhibited by antiviral drugs. Similarly, these latent viruses are not detected by the immune system. In this review, we discuss HIV-1 latency and the mechanisms that allow this pathogenic retrovirus to hide and persist by exploiting the cellular vehicles of immunological memory.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Barré-Sinoussi, F., Chermann, J. C., Rey, F., Nugeyre, M. T., Chamaret, S., Gruest, J., Dauguet, C., Axler-Blin, C., Vézinet-Brun, F., Rouzioux, C., et al. (1983) · Science · doi:10.1126/science.6189183 · Cited by 7,038
Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection
Ho, D. D., Neumann, A. U., Perelson, A. S., Chen, W., Leonard, J. M., & Markowitz, M. (1995) · Nature · doi:10.1038/373123a0 · Cited by 4,267
Gallo, R. C., Salahuddin, S. Z., Popovic, M., Shearer, G. M., Kaplan, M., Haynes, B. F., Palker, T. J., Redfield, R., Oleske, J., Safai, B., et al. (1984) · Science · doi:10.1126/science.6200936 · Cited by 3,641
Popovic, M., Sarngadharan, M. G., Read, E., & Gallo, R. C. (1984) · Science · doi:10.1126/science.6200935 · Cited by 3,535
Viral dynamics in human immunodeficiency virus type 1 infection
Wei, X., Ghosh, S. K., Taylor, M. E., Johnson, V. A., Emini, E. A., Deutsch, P., Lifson, J. D., Bonhoeffer, S., Nowak, M. A., Hahn, B. H., et al. (1995) · Nature · doi:10.1038/373117a0 · Cited by 3,260
Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy
Finzi, D., Hermankova, M., Pierson, T., Carruth, L. M., Buck, C., Chaisson, R. E., Quinn, T. C., Chadwick, K., Margolick, J., Brookmeyer, R., et al. (1997) · Science · doi:10.1126/science.278.5341.1295 · Cited by 3,098
Gottlieb, M. S., Schroff, R., Schanker, H. M., Weisman, J. D., Fan, P. T., Wolf, R. A., & Saxon, A. (1981) · New England Journal of Medicine · doi:10.1056/nejm198112103052401 · Cited by 2,728
Recovery of replication-competent HIV despite prolonged suppression of plasma viremia
Wong, J. K., Hezareh, M., Günthard, H. F., Havlir, D. V., Ignacio, C. C., Spina, C. A., & Richman, D. D. (1997) · Science · doi:10.1126/science.278.5341.1291 · Cited by 2,186
Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy
Chun, T.-W., Stuyver, L., Mizell, S. B., Ehler, L. A., Mican, J. A. M., Baseler, M., Lloyd, A. L., Nowak, M. A., & Fauci, A. S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13193 · Cited by 1,977
Decay characteristics of HIV-1-infected compartments during combination therapy
Perelson, A. S., Essunger, P., Cao, Y., Vesanen, M., Hurley, A., Saksela, K., Markowitz, M., & Ho, D. D. (1997) · Nature · doi:10.1038/387188a0 · Cited by 1,880
HIV-1 Integration in the Human Genome Favors Active Genes and Local Hotspots
Schröder, A. R. W., Shinn, P., Chen, H., Berry, C., Ecker, J. R., & Bushman, F. (2002) · Cell · doi:10.1016/s0092-8674(02)00864-4 · Cited by 1,832
HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation
Chomont, N., El-Far, M., Ancuta, P., Trautmann, L., Procopio, F. A., Yassine-Diab, B., Boucher, G., Boulassel, M.-R., Ghattas, G., Brenchley, J. M., et al. (2009) · Nature Medicine · doi:10.1038/nm.1972 · Cited by 1,722
Siliciano, J. D., Kajdas, J., Finzi, D., Quinn, T. C., Chadwick, K., Margolick, J. B., Kovacs, C., Gange, S. J., & Siliciano, R. F. (2003) · Nature Medicine · doi:10.1038/nm880 · Cited by 1,703
Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure
Ho, Y.-C., Shan, L., Hosmane, N. N., Wang, J., Laskey, S. B., Rosenbloom, D. I. S., Lai, J., Blankson, J. N., Siliciano, J. D., & Siliciano, R. F. (2013) · Cell · doi:10.1016/j.cell.2013.09.020 · Cited by 1,405
Wei, P., Garber, M. E., Fang, S.-M., Fischer, W. H., & Jones, K. A. (1998) · Cell · doi:10.1016/s0092-8674(00)80939-3 · Cited by 1,249
Siegal, F. P., Lopez, C., Hammer, G. S., Brown, A. E., Kornfeld, S. J., Gold, J., Hassett, J., Hirschman, S. Z., Cunningham-Rundles, C., Adelsberg, B. R., et al. (1981) · New England Journal of Medicine · doi:10.1056/nejm198112103052403 · Cited by 1,246
Steady-state and inflammatory dendritic-cell development
Shortman, K., & Naik, S. H. (2007) · Nature Reviews Immunology · doi:10.1038/nri1996 · Cited by 1,190
Sarngadharan, M. G., Popovic, M., Bruch, L., Schüpbach, J., & Gallo, R. C. (1984) · Science · doi:10.1126/science.6324345 · Cited by 1,148
Sáez-Cirión, A., Bacchus, C., Hocqueloux, L., Avettand-Fenoel, V., Girault, I., Lecuroux, C., Potard, V., Versmisse, P., Melard, A., Prazuck, T., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003211 · Cited by 1,011
The Phosphorylation Status of Nuclear NF-ΚB Determines Its Association with CBP/p300 or HDAC-1
Zhong, H., May, M. J., Jimi, E., & Ghosh, S. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00477-x · Cited by 939
Small Interfering RNA-Induced Transcriptional Gene Silencing in Human Cells
Morris, K. V., Chan, S. W.-L., Jacobsen, S. E., & Looney, D. J. (2004) · Science · doi:10.1126/science.1101372 · Cited by 925
Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product
Kao, S.-Y., Calman, A. F., Luciw, P. A., & Peterlin, B. M. (1987) · Nature · doi:10.1038/330489a0 · Cited by 909
Chun, T.-W., Engel, D., Berrey, M. M., Shea, T., Corey, L., & Fauci, A. S. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8869 · Cited by 846
In vivo fate of HIV-1-infected T cells: Quantitative analysis of the transition to stable latency
Chun, T.-W., Finzi, D., Margolick, J., Chadwick, K., Schwartz, D., & Siliciano, R. F. (1995) · Nature Medicine · doi:10.1038/nm1295-1284 · Cited by 787
Shan, L., Deng, K., Shroff, N. S., Durand, C. M., Rabi, S. A., Yang, H.-C., Zhang, H., Margolick, J. B., Blankson, J. N., & Siliciano, R. F. (2012) · Immunity · doi:10.1016/j.immuni.2012.01.014 · Cited by 714
HIV-1 Integrase Forms Stable Tetramers and Associates with LEDGF/p75 Protein in Human Cells
Cherepanov, P., Maertens, G., Proost, P., Devreese, B., Van Beeumen, J., Engelborghs, Y., De Clercq, E., & Debyser, Z. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209278200 · Cited by 704
Evidence for the cure of HIV infection by CCR5Δ32/Δ32 stem cell transplantation
Allers, K., Hütter, G., Hofmann, J., Loddenkemper, C., Rieger, K., Thiel, E., & Schneider, T. (2011) · Blood · doi:10.1182/blood-2010-09-309591 · Cited by 681
Infection of monocyte/macrophages by human T lymphotropic virus type III.
Ho, D. D., Rota, T. R., & Hirsch, M. S. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112491 · Cited by 672
Weinberger, L. S., Burnett, J. C., Toettcher, J. E., Arkin, A. P., & Schaffer, D. V. (2005) · Cell · doi:10.1016/j.cell.2005.06.006 · Cited by 630
Schüpbach, J., Popovic, M., Gilden, R. V., Gonda, M. A., Sarngadharan, M. G., & Gallo, R. C. (1984) · Science · doi:10.1126/science.6200937 · Cited by 610
Van Lint, C., Emiliani, S., Ott, M., & Verdin, E. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00449.x · Cited by 580
Persistence of HIV in Gut‐Associated Lymphoid Tissue despite Long‐Term Antiretroviral Therapy
Chun, T., Nickle, D. C., Justement, J. S., Meyers, J. H., Roby, G., Hallahan, C. W., Kottilil, S., Moir, S., Mican, J. M., Mullins, J. I., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/527324 · Cited by 574
J Buzón, M., Massanella, M., Llibre, J. M., Esteve, A., Dahl, V., Puertas, M. C., Gatell, J. M., Domingo, P., Paredes, R., Sharkey, M., et al. (2010) · Nature Medicine · doi:10.1038/nm.2111 · Cited by 551
(2003) · PubMed · Cited by 519
Verdin, E., Paras, P., & Van Lint, C. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05994.x · Cited by 510
Depletion of latent HIV-1 infection in vivo: a proof-of-concept study
Lehrman, G., Hogue, I. B., Palmer, S., Jennings, C., Spina, C. A., Wiegand, A., Landay, A. L., Coombs, R. W., Richman, D. D., Mellors, J. W., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67098-5 · Cited by 510
A cooperative interaction between NF-kappa B and Sp1 is required for HIV-1 enhancer activation.
Perkins, N. D., Edwards, N. L., Duckett, C. S., Agranoff, A. B., Schmid, R. M., & Nabel, G. J. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb06029.x · Cited by 484
Yik, J. H. N., Chen, R., Nishimura, R., Jennings, J. L., Link, A. J., & Zhou, Q. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00388-5 · Cited by 466
Dornadula, G. (1999) · JAMA · doi:10.1001/jama.282.17.1627 · Cited by 463
Approaches for the sequence-specific knockdown of mRNA
Scherer, L. J., & Rossi, J. J. (2003) · Nature Biotechnology · doi:10.1038/nbt915 · Cited by 455
Dinoso, J. B., Kim, S. Y., Wiegand, A. M., Palmer, S. E., Gange, S. J., Cranmer, L., O'Shea, A., Callender, M., Spivak, A., Brennan, T., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903107106 · Cited by 441
NF-κB Binds P-TEFb to Stimulate Transcriptional Elongation by RNA Polymerase II
Barboric, M., Nissen, R. M., Kanazawa, S., Jabrane-Ferrat, N., & Peterlin, B. M. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00314-8 · Cited by 435
NF‐κB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation
Williams, S. A., Chen, L., Kwon, H., Ruiz‐Jarabo, C. M., Verdin, E., & Greene, W. C. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7600900 · Cited by 430
Self-citationIntermittent HIV-1 Viremia (Blips) and Drug Resistance in Patients Receiving HAART
Nettles, R. E. (2005) · JAMA · doi:10.1001/jama.293.7.817 · Cited by 395
Epigenetic Regulation of HIV-1 Latency by Cytosine Methylation
Kauder, S. E., Bosque, A., Lindqvist, A., Planelles, V., & Verdin, E. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000495 · Cited by 374
Fujinaga, K., Irwin, D., Huang, Y., Taube, R., Kurosu, T., & Peterlin, B. M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.2.787-795.2004 · Cited by 371
Retroviral DNA integration: viral and cellular determinants of target-site selection
Lewinski, M. K., Yamashita, M., Emerman, M., Ciuffi, A., Marshall, H., Crawford, G., Collins, F., Shinn, P., Leipzig, J., Hannenhalli, S., et al. (2006) · PLoS Pathogens · doi:10.1371/journal.ppat.0020060 · Cited by 364
Induction of HIV-1 Replication in Latently Infected CD4+ T Cells Using a Combination of Cytokines
Chun, T.-W., Engel, D., Mizell, S. B., Ehler, L. A., & Fauci, A. S. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.1.83 · Cited by 359
Expression of Latent HIV Induced by the Potent HDAC Inhibitor Suberoylanilide Hydroxamic Acid
Archin, N. M., Espeseth, A., Parker, D., Cheema, M., Hazuda, D., & Margolis, D. M. (2009) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2008.0191 · Cited by 336
CpG Methylation Controls Reactivation of HIV from Latency
Blazkova, J., Trejbalova, K., Gondois-Rey, F., Halfon, P., Philibert, P., Guiguen, A., Verdin, E., Olive, D., Van Lint, C., Hejnar, J., et al. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000554 · Cited by 333
SIRT1 Regulates HIV Transcription via Tat Deacetylation
Pagans, S., Pedal, A., North, B. J., Kaehlcke, K., Marshall, B. L., Dorr, A., Hetzer-Egger, C., Henklein, P., Frye, R., McBurney, M. W., et al. (2005) · PLoS Biology · doi:10.1371/journal.pbio.0030041 · Cited by 331
Han, Y., Lassen, K., Monie, D., Sedaghat, A. R., Shimoji, S., Liu, X., Pierson, T. C., Margolick, J. B., Siliciano, R. F., & Siliciano, J. D. (2004) · Journal of Virology · doi:10.1128/jvi.78.12.6122-6133.2004 · Cited by 327
Prostratin Antagonizes HIV Latency by Activating NF-κB
Williams, S. A., Chen, L.-F., Kwon, H., Fenard, D., Bisgrove, D., Verdin, E., & Greene, W. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402124200 · Cited by 318
Self-citationGandhi, R. T., Zheng, L., Bosch, R. J., Chan, E. S., Margolis, D. M., Read, S., Kallungal, B., Palmer, S., Medvik, K., Lederman, M. M., et al. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000321 · Cited by 304
Li, Z., Guo, J., Wu, Y., & Zhou, Q. (2013) · Nucleic Acids Research · doi:10.1093/nar/gks976 · Cited by 301
Yukl, S. A., Boritz, E., Busch, M., Bentsen, C., Chun, T.-W., Douek, D., Eisele, E., Haase, A., Ho, Y.-C., Hütter, G., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003347 · Cited by 291
Genome-Wide Analysis of Chromosomal Features Repressing Human Immunodeficiency Virus Transcription
Lewinski, M. K., Bisgrove, D., Shinn, P., Chen, H., Hoffmann, C., Hannenhalli, S., Verdin, E., Berry, C. C., Ecker, J. R., & Bushman, F. D. (2005) · Journal of Virology · doi:10.1128/jvi.79.11.6610-6619.2005 · Cited by 270
BET bromodomain inhibition as a novel strategy for reactivation of HIV-1
Banerjee, C., Archin, N., Michaels, D., Belkina, A. C., Denis, G. V., Bradner, J., Sebastiani, P., Margolis, D. M., & Montano, M. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0312165 · Cited by 256
Transcriptional Interference Antagonizes Proviral Gene Expression to Promote HIV Latency
Lenasi, T., Contreras, X., & Peterlin, B. M. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.05.016 · Cited by 245
HIV interactions with monocytes and dendritic cells: viral latency and reservoirs
Coleman, C. M., & Wu, L. (2009) · Retrovirology · doi:10.1186/1742-4690-6-51 · Cited by 245
Reuse, S., Calao, M., Kabeya, K., Guiguen, A., Gatot, J.-S., Quivy, V., Vanhulle, C., Lamine, A., Vaira, D., Demonte, D., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006093 · Cited by 240
He, G., & Margolis, D. M. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.9.2965-2973.2002 · Cited by 240
Structural Basis of Lysine-Acetylated HIV-1 Tat Recognition by PCAF Bromodomain
Mujtaba, S., He, Y., Zeng, L., Farooq, A., Carlson, J. E., Ott, M., Verdin, E., & Zhou, M.-M. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00483-5 · Cited by 239
BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism
Boehm, D., Calvanese, V., Dar, R. D., Xing, S., Schroeder, S., Martins, L., Aull, K., Li, P.-C., Planelles, V., Bradner, J. E., et al. (2013) · Cell Cycle · doi:10.4161/cc.23309 · Cited by 235
Host Control of HIV-1 Parasitism in T Cells by the Nuclear Factor of Activated T Cells
Kinoshita, S., Chen, B. K., Kaneshima, H., & Nolan, G. P. (1998) · Cell · doi:10.1016/s0092-8674(00)81630-x · Cited by 227
Domains in the SPT5 Protein That Modulate Its Transcriptional Regulatory Properties
Ivanov, D., Kwak, Y. T., Guo, J., & Gaynor, R. B. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.9.2970-2983.2000 · Cited by 221
CBF‐1 promotes transcriptional silencing during the establishment of HIV‐1 latency
Tyagi, M., & Karn, J. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601928 · Cited by 220
Jiang, G., Espeseth, A., Hazuda, D. J., & Margolis, D. M. (2007) · Journal of Virology · doi:10.1128/jvi.01208-07 · Cited by 218
HMBA Releases P-TEFb from HEXIM1 and 7SK snRNA via PI3K/Akt and Activates HIV Transcription
Contreras, X., Barboric, M., Lenasi, T., & Peterlin, B. M. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030146 · Cited by 206
Persistence of Infectious HIV on Follicular Dendritic Cells
Smith, B. A., Gartner, S., Liu, Y., Perelson, A. S., Stilianakis, N. I., Keele, B. F., Kerkering, T. M., Ferreira-Gonzalez, A., Szakal, A. K., Tew, J. G., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.1.690 · Cited by 204
Kieffer, T. L., Finucane, M. M., Nettles, R. E., Quinn, T. C., Broman, K. W., Ray, S. C., Persaud, D., & Siliciano, R. F. (2004) · The Journal of Infectious Diseases · doi:10.1086/382488 · Cited by 201
Keedy, K. S., Archin, N. M., Gates, A. T., Espeseth, A., Hazuda, D. J., & Margolis, D. M. (2009) · Journal of Virology · doi:10.1128/jvi.02585-08 · Cited by 200
Bartholomeeusen, K., Xiang, Y., Fujinaga, K., & Peterlin, B. M. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.410746 · Cited by 197
García-Rodríguez, C., & Rao, A. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.12.2031 · Cited by 195
Molecular Characterization, Reactivation, and Depletion of Latent HIV
Brooks, D. G., Hamer, D. H., Arlen, P. A., Gao, L., Bristol, G., Kitchen, C. M. R., Berger, E. A., & Zack, J. A. (2003) · Immunity · doi:10.1016/s1074-7613(03)00236-x · Cited by 192
Stability of the Latent Reservoir for HIV‐1 in Patients Receiving Valproic Acid
Siliciano, J. D., Lai, J., Callender, M., Pitt, E., Zhang, H., Margolick, J. B., Gallant, J. E., Cofrancesco, Jr., Moore, R. D., Gange, S. J., et al. (2007) · The Journal of Infectious Diseases · doi:10.1086/511823 · Cited by 182
Kim, Y. K., Bourgeois, C. F., Isel, C., Churcher, M. J., & Karn, J. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.13.4622-4637.2002 · Cited by 178
Transcription elongation factors DSIF and NELF: Promoter-proximal pausing and beyond
Yamaguchi, Y., Shibata, H., & Handa, H. (2013) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2012.11.007 · Cited by 176
Prolonged valproic acid treatment does not reduce the size of latent HIV reservoir
Lerolle, N., Lamine, A., Chaix, M., Boufassa, F., Aboulker, J.-P., Costagliola, D. G., Goujard, C., Paller, C., Delfraissy, J., & Lambotte, O. (2008) · AIDS · doi:10.1097/qad.0b013e3282fd6ddc · Cited by 158
Molecular mechanisms of neuroinvasion by monocytes-macrophages in HIV-1 infection
Gras, G. S., & Kaul, M. (2010) · Retrovirology · doi:10.1186/1742-4690-7-30 · Cited by 150
van Praag, R. M. E., Prins, J. M., Roos, M. T. L., Schellekens, P. T. A., ten Berge, I. J. M., Yong, S. L., Schuitemaker, H., Eerenberg, A. J. M., Jurriaans, S., de Wolf, F., et al. (2001) · Journal of Clinical Immunology · doi:10.1023/a:1011091300321 · Cited by 140
NFAT1 Enhances HIV-1 Gene Expression in Primary Human CD4 T Cells
Cron, R. Q., Bartz, S. R., Clausell, A., Bort, S. J., Klebanoff, S. J., & Lewis, D. B. (2000) · Clinical Immunology · doi:10.1006/clim.1999.4831 · Cited by 133
Recruitment of TFIIH to the HIV LTR is a rate‐limiting step in the emergence of HIV from latency
Kim, Y. K., Bourgeois, C. F., Pearson, R., Tyagi, M., West, M. J., Wong, J. Y., Wu, S.-Y., Chiang, C., & Karn, J. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601248 · Cited by 131
Acetylation of Tat Defines a CyclinT1-Independent Step in HIV Transactivation
Kaehlcke, K., Dorr, A., Hetzer‐Egger, C., Kiermer, V., Henklein, P., Schnoelzer, M., Loret, E. P., Cole, P. A., Verdin, E. M., & Ott, M. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00245-4 · Cited by 129
Evering, T. H., Mehandru, S., Rácz, P., Tenner‐Racz, K., Poles, M. A., Figueroa, A., Mohri, H., & Markowitz, M. H. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002506 · Cited by 128
Stellbrink, H., van Lunzen, J., Westby, M., O’Sullivan, E., Schneider, C. G., Adam, A., Weitner, L., Kuhlmann, B., Hoffmann, C., Fenske, S., et al. (2002) · AIDS · doi:10.1097/00002030-200207260-00004 · Cited by 123
Kim, Y. K., Mbonye, U. R., Hokello, J. F., & Karn, J. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.03.054 · Cited by 121
Transcriptional interference perturbs the binding of Sp1 to the HIV-1 promoter
Greger, I. H. (1998) · Nucleic Acids Research · doi:10.1093/nar/26.5.1294 · Cited by 118
Bryostatin-1 Synergizes with Histone Deacetylase Inhibitors to Reactivate HIV-1 from Latency
Pérez, M., de Vinuesa, A. G., Sánchez‐Duffhues, G., Márquez, N., Bellido, M., Muñoz‐Fernández, M. Á., Moreno, S., Castor, T. P., Calzado, M. A., & Muñóz, E. (2010) · Current HIV Research · doi:10.2174/157016210793499312 · Cited by 116
He, N., Pezda, A. C., & Zhou, Q. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00778-06 · Cited by 100
Blažková, J., Murray, D., Justement, J. S., Funk, E. K., Nelson, A. K., Moir, S. L., Chun, T., & Fauci, A. S. (2012) · Journal of Virology · doi:10.1128/jvi.00040-12 · Cited by 93
Dybul, M. R., Hidalgo, B., Chun, T., Belson, M., Migueles, S. A., Justement, J. S., Herpin, B. R., Perry, C. H., Hallahan, C. W., Davey, R. T., et al. (2002) · The Journal of Infectious Diseases · doi:10.1086/338123 · Cited by 82
Hexamethylbisacetamide and Disruption of Human Immunodeficiency Virus Type 1 Latency in CD4+T Cells
Choudhary, S. K., Archin, N. M., & Margolis, D. M. (2008) · The Journal of Infectious Diseases · doi:10.1086/529525 · Cited by 73
Bednarik, D. P., Duckett, C. S., Kim, S. U., Perez, V. L., Griffis, K., Guenthner, P. C., & Folks, T. M. (1991) · PubMed · Cited by 62
Lafeuillade, A., Poggi, C., Chadapaud, S., Hittinger, G., Chouraqui, M., Pisapia, M., & Delbeke, E. (2001) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00042560-200101010-00006 · Cited by 57
Long-Term Productive Human Immunodeficiency Virus Infection of CD1a-Sorted Myeloid Dendritic Cells
Popov, S., Chenine, A.-L., Gruber, A., Li, P., & Ruprecht, R. M. (2004) · Journal of Virology · doi:10.1128/jvi.79.1.602-608.2005 · Cited by 56
Otero, M. A., Nunnari, G., Leto, D., Sullivan, J., Wang, F., Frank, I., Xu, Y., Patel, C. A., Dornadula, G., Kulkosky, J., et al. (2003) · AIDS Research and Human Retroviruses · doi:10.1089/088922203771881194 · Cited by 54
Hezareh, M., Moukil, M. A., Szántó, I., Pondarzewski, M., Mouche, S., Cherix, N., Brown, S. J., Carpentier, J., & Foti, M. (2004) · Antiviral chemistry & chemotherapy · doi:10.1177/095632020401500404 · Cited by 51
RNA interference against retroviruses
Hu, W.-Y., Bushman, F. D., & Siva, A. C. (2004) · Virus Research · doi:10.1016/j.virusres.2004.01.016 · Cited by 28
Cited by
Defective proviruses rapidly accumulate during acute HIV-1 infection
Bruner, K. M., Murray, A. J., Pollack, R. A., Soliman, M. G., Laskey, S. B., Capoferri, A. A., Lai, J., Strain, M. C., Lada, S. M., Hoh, R., et al. (2016) · Nature Medicine · doi:10.1038/nm.4156 · Cited by 737
Getting the “Kill” into “Shock and Kill”: Strategies to Eliminate Latent HIV
Kim, Y., Anderson, J. L., & Lewin, S. R. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2017.12.004 · Cited by 414
Einkauf, K. B., Lee, G. Q., Gao, C., Sharaf, R., Sun, X., Hua, S., Chen, S. M. Y., Jiang, C., Lian, X., Chowdhury, F. Z., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci124291 · Cited by 295
Elimination of HIV-1-infected cells by broadly neutralizing antibodies
Bruel, T., Guivel-Benhassine, F., Amraoui, S., Malbec, M., Richard, L., Bourdic, K., Donahue, D. A., Lorin, V., Casartelli, N., Noël, N., et al. (2016) · Nature Communications · doi:10.1038/ncomms10844 · Cited by 271
Predicting the outcomes of treatment to eradicate the latent reservoir for HIV-1
Hill, A. L., Rosenbloom, D. I. S., Fu, F., Nowak, M. A., & Siliciano, R. F. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1406663111 · Cited by 265
Metadata
- Authors
- Ruelas, D. S., & Greene, W. C.
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2013-10
- Volume
- 155
- Issue
- 3
- Pages
- 519-529
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W2049653440
- Cited by
- 324
- References
- 99
- FWCI
- 11.27
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.